<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35848380</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2044</ISSN><JournalIssue CitedMedium="Internet"><Volume>77</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Anaesthesia</Title><ISOAbbreviation>Anaesthesia</ISOAbbreviation></Journal><ArticleTitle>The COVID-19 pandemic and its consequences for chronic pain: a narrative review.</ArticleTitle><Pagination><StartPage>1039</StartPage><EndPage>1050</EndPage><MedlinePgn>1039-1050</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/anae.15801</ELocationID><Abstract><AbstractText>The COVID-19 pandemic transformed everyday life, but the implications were most impactful for vulnerable populations, including patients with chronic pain. Moreover, persistent pain is increasingly recognised as a key manifestation of long COVID. This narrative review explores the consequences of the COVID-19 pandemic for chronic pain. Publications were identified related to the COVID-19 pandemic influence on the burden of chronic pain, development of new-onset pain because of long COVID with proposed mechanisms and COVID-19 vaccines and pain interventions. Broadly, mechanisms underlying pain due to SARS-CoV-2 infection could be caused by 'systemic inflammatory-immune mechanisms', 'direct neuropathic mechanisms' or 'secondary mechanisms due to the viral infection or treatment'. Existing chronic pain populations were variably impacted and social determinants of health appeared to influence the degree of effect. SARS-CoV-2 infection increased the absolute numbers of patients with pain and headache. In the acute phase, headache as a presenting symptom predicted a milder course. New-onset chronic pain was reportedly common and likely involves multiple mechanisms; however, its prevalence decreases over time and symptoms appear to fluctuate. Patients requiring intensive support were particularly susceptible to long COVID symptoms. Some evidence suggests steroid exposure (often used for pain interventions) may affect vaccine efficacy, but there is no evidence of clinical repercussions to date. Although existing chronic pain management could help with symptomatic relief, there is a need to advance research focusing on mechanism-based treatments within the domain of multidisciplinary care.</AbstractText><CopyrightInformation>&#xa9; 2022 Association of Anaesthetists.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shanthanna</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nelson</LastName><ForeName>A M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Care, University of California Irvine, Orange, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kissoon</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Narouze</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Pain Medicine, Western Reserve Hospital, Cuyahoga Falls, OH, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Anaesthesia</MedlineTA><NlmUniqueID>0370524</NlmUniqueID><ISSNLinking>0003-2409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059350" MajorTopicYN="Y">Chronic Pain</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006261" MajorTopicYN="N">Headache</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">chronic pain</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">pain practice</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19 syndrome</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>18</Day><Hour>5</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35848380</ArticleId><ArticleId IdType="pmc">PMC9350079</ArticleId><ArticleId IdType="doi">10.1111/anae.15801</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
World Health Organization
. WHO coronavirus (COVID&#x2010;19) dashboard. https://covid19.who.int (accessed 14/02/2022).</Citation></Reference><Reference><Citation>Szilagyi IS, Ullrich T, Lang&#x2010;Illievich K, et&#x2009;al. Google trends for pain search terms in the world's most populated regions before and after the first recorded COVID&#x2010;19 case: Infodemiological study. Journal of Medical Internet Research 2021; 23: e27214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8064706</ArticleId><ArticleId IdType="pubmed">33844638</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID&#x2010;19 Mental Disorders Collaborators . Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID&#x2010;19 pandemic. Lancet 2021; 398: 1700&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8500697</ArticleId><ArticleId IdType="pubmed">34634250</ArticleId></ArticleIdList></Reference><Reference><Citation>Saladino V, Algeri D, Auriemma V. The psychological and social impact of Covid&#x2010;19: new perspectives of well&#x2010;being. Frontiers in Psychology 2020; 11: 577684.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7561673</ArticleId><ArticleId IdType="pubmed">33132986</ArticleId></ArticleIdList></Reference><Reference><Citation>Imtiaz S, Nafeh F, Russell C, Ali F, Elton&#x2010;Marshall T, Rehm J. The impact of the novel coronavirus disease (COVID&#x2010;19) pandemic on drug overdose&#x2010;related deaths in the United States and Canada: a systematic review of observational studies and analysis of public health surveillance data. Substance Abuse Treatment, Prevention, and Policy 2021; 16: 87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8628272</ArticleId><ArticleId IdType="pubmed">34844624</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopanczyk R, Kumar N, Papadimos T. Post&#x2010;acute COVID&#x2010;19 syndrome for anesthesiologists: a narrative review and a pragmatic approach to clinical care. Journal of Cardiothoracic and Vascular Anesthesia 2021; 36: 2727&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8487462</ArticleId><ArticleId IdType="pubmed">34688543</ArticleId></ArticleIdList></Reference><Reference><Citation>Dro&#x17c;d&#x17c;al S, Rosik J, Lechowicz K, et&#x2009;al. COVID&#x2010;19: pain management in patients with SARS&#x2010;CoV&#x2010;2 infection&#x2010;molecular mechanisms, challenges, and perspectives. Brain Sciences 2020; 10: 465.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7407489</ArticleId><ArticleId IdType="pubmed">32698378</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng LM, Su X, Wang XQ. Pain symptoms in patients with coronavirus disease (COVID&#x2010;19): a literature review. Journal of Pain Research 2021; 14: 147&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7847371</ArticleId><ArticleId IdType="pubmed">33531833</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp HI, Corner E, Colvin LA. Chronic pain after COVID&#x2010;19: implications for rehabilitation. British Journal of Anaesthesia 2020; 125: 436&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7261464</ArticleId><ArticleId IdType="pubmed">32560913</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin R. As their numbers grow, COVID&#x2010;19 &#x201c;long haulers&#x201d; stump experts. Journal of the American Medical Association 2020; 324: 1381&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">32965460</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer&#x2010;Frie&#xdf;em CH, Gierthm&#xfc;hlen J, Baron R, Sommer C, &#xdc;&#xe7;eyler N, Enax&#x2010;Krumova EK. Pain during and after COVID&#x2010;19 in Germany and worldwide: a narrative review of current knowledge. Pain Reports 2021; 6: e893.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7819701</ArticleId><ArticleId IdType="pubmed">33490851</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaarslan F, Demircio&#x11f;lu G&#xfc;neri F, Karde&#x15f; S. Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID&#x2010;19: prospective follow&#x2010;up by phone interviews. Rheumatology International 2021; 41: 1263&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8114015</ArticleId><ArticleId IdType="pubmed">33978818</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojeda A, Calvo A, Cu&#xf1;at T, et&#x2009;al. Characteristics and influence on quality of life of new&#x2010;onset pain in critical COVID&#x2010;19 survivors. European Journal of Pain 2022; 26: 680&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9015597</ArticleId><ArticleId IdType="pubmed">34866276</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention
. Post&#x2010;COVID conditions: information for healthcare providers. 2022. https://www.cdc.gov/coronavirus/2019&#x2010;ncov/hcp/clinical&#x2010;care/post&#x2010;covid&#x2010;conditions.html (accessed 14/02/2022).</Citation></Reference><Reference><Citation>Cipollaro L, Giordano L, Padulo J, Oliva F, Maffulli N. Musculoskeletal symptoms in SARS&#x2010;CoV&#x2010;2 (COVID&#x2010;19) patients. Journal of Orthopaedic Surgery and Research 2020; 15: 178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7232908</ArticleId><ArticleId IdType="pubmed">32423471</ArticleId></ArticleIdList></Reference><Reference><Citation>Oguz&#x2010;Akarsu E, Gullu G, Kilic E, et&#x2009;al. Insight into pain syndromes in acute phase of mild&#x2010;to&#x2010;moderate COVID&#x2010;19: frequency, clinical characteristics, and associated factors. European Journal of Pain 2022; 26: 492&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8653127</ArticleId><ArticleId IdType="pubmed">34622527</ArticleId></ArticleIdList></Reference><Reference><Citation>Struyf T, Deeks JJ, Dinnes J, et&#x2009;al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID&#x2010;19 disease. Cochrane Database of Systematic Reviews 2020; 7: CD013665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7386785</ArticleId><ArticleId IdType="pubmed">32633856</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez&#x2010;de&#x2010;Las&#x2010;Pe&#xf1;as C, Navarro&#x2010;Santana M, G&#xf3;mez&#x2010;Mayordomo V, et&#x2009;al. Headache as an acute and post&#x2010;COVID&#x2010;19 symptom in COVID&#x2010;19 survivors: a meta&#x2010;analysis of the current literature. European Journal of Neurology 2021; 28: 3820&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444899</ArticleId><ArticleId IdType="pubmed">34327787</ArticleId></ArticleIdList></Reference><Reference><Citation>Caronna E, Ballv&#xe9; A, Llaurad&#xf3; A, et&#x2009;al. Headache: a striking prodromal and persistent symptom, predictive of COVID&#x2010;19 clinical evolution. Cephalalgia 2020; 40: 1410&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7645597</ArticleId><ArticleId IdType="pubmed">33146036</ArticleId></ArticleIdList></Reference><Reference><Citation>Knox N, Lee CS, Moon JY, Cohen SP. Pain manifestations of COVID&#x2010;19 and their association with mortality: a multicenter prospective observational study. Mayo Clinic Proceedings 2021; 96: 943&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7764470</ArticleId><ArticleId IdType="pubmed">33722397</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez&#x2010;de&#x2010;Las&#x2010;Pe&#xf1;as C, Rodr&#xed;guez&#x2010;Jim&#xe9;nez J, Fuensalida&#x2010;Novo S, et&#x2009;al. Myalgia as a symptom at hospital admission by severe acute respiratory syndrome coronavirus 2 infection is associated with persistent musculoskeletal pain as long&#x2010;term post&#x2010;COVID sequelae: a case&#x2010;control study. Pain 2021; 162: 2832&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">33863864</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID&#x2010;19. Journal of the American Medical Association 2020; 324: 603&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada K, Wakaizumi K, Kubota Y, Murayama H, Tabuchi T. Loneliness, social isolation, and pain following the COVID&#x2010;19 outbreak: data from a nationwide internet survey in Japan. Scientific Reports 2021; 11: 18643.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8452720</ArticleId><ArticleId IdType="pubmed">34545110</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares FHC, Kubota GT, Fernandes AM, et&#x2009;al. Prevalence and characteristics of new&#x2010;onset pain in COVID&#x2010;19 survivors, a controlled study. European Journal of Pain 2021; 25: 1342&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013219</ArticleId><ArticleId IdType="pubmed">33619793</ArticleId></ArticleIdList></Reference><Reference><Citation>FAIR Health . A detailed study of patients with long&#x2010;haul COVID. An analysis of private healthcare claims. 2021.</Citation></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, et&#x2009;al. Post&#x2010;discharge persistent symptoms and health&#x2010;related quality of life after hospitalization for COVID&#x2010;19. Journal of Infection 2020; 81: e4&#x2013;e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez&#x2010;de&#x2010;Las&#x2010;Pe&#xf1;as C, Navarro&#x2010;Santana M, Plaza&#x2010;Manzano G, Palacios&#x2010;Ce&#xf1;a D, Arendt&#x2010;Nielsen L. Time course prevalence of post&#x2010;COVID pain symptoms of musculoskeletal origin in patients who had survived to severe acute respiratory syndrome coronavirus 2 infection: a systematic review and meta&#x2010;analysis. Pain 2022; 163: 1220&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">34561390</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaarslan F, G&#xfc;neri FD, Karde&#x15f; S. Long OVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID&#x2010;19 survivors at 3 and 6 months. Clinical Rheumatology 2022; 41: 289&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8553494</ArticleId><ArticleId IdType="pubmed">34713356</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuan WJ, Spotts H, Zgierska AE, Lennon RP. COVID&#x2010;19 outcomes among adult patients treated with long&#x2010;term opioid therapy for chronic non&#x2010;cancer pain in the USA: a retrospective cohort study. British Medical Journal Open 2021; 11: e056436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8628115</ArticleId><ArticleId IdType="pubmed">34836910</ArticleId></ArticleIdList></Reference><Reference><Citation>Ao G, Li A, Wang Y, et&#x2009;al. Opioid usage and COVID&#x2010;19 prognosis: a systematic review and meta&#x2010;analysis. American Journal of Emergency Medicine 2022; 56: 51&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8957893</ArticleId><ArticleId IdType="pubmed">35366438</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu EA, Salazar T, Chiu E, et&#x2009;al. Focal peripheral neuropathies observed in patients diagnosed with COVID&#x2010;19: a case series. American Journal of Physical Medicine and Rehabilitation 2022; 101: 164&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8745887</ArticleId><ArticleId IdType="pubmed">35026778</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik GR, Wolfe AR, Soriano R, et&#x2009;al. Injury&#x2010;prone: peripheral nerve injuries associated with prone positioning for COVID&#x2010;19&#x2010;related acute respiratory distress syndrome. British Journal of Anaesthesia 2020; 125: e478&#x2013;e480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7473147</ArticleId><ArticleId IdType="pubmed">32948295</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, et&#x2009;al. Postdischarge symptoms and rehabilitation needs in survivors of COVID&#x2010;19 infection: a cross&#x2010;sectional evaluation. Journal of Medical Virology 2021; 93: 1013&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojeda A, Calvo A, Cu&#xf1;at T, et&#x2009;al. Rationale and study design of an early care, therapeutic education, and psychological intervention program for the management of post&#x2010;intensive care syndrome and chronic pain after COVID&#x2010;19 infection (PAIN&#x2010;COVID): study protocol for a randomized controlled trial. Trials 2021; 22: 486.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8310406</ArticleId><ArticleId IdType="pubmed">34303381</ArticleId></ArticleIdList></Reference><Reference><Citation>Scordo KA, Richmond MM, Munro N. Post&#x2010;COVID&#x2010;19 syndrome: theoretical basis, identification, and management. American Association of Critical&#x2010;Care Nurses Advanced Critical Care 2021; 32: 188&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">33942071</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post&#x2010;SARS syndrome; a case&#x2010;controlled study. BMC Neurology 2011; 11: 37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Su S, Cui H, Wang T, Shen X, Ma C. Pain: a potential new label of COVID&#x2010;19. Brain, Behavior, and Immunity 2020; 87: 159&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7204693</ArticleId><ArticleId IdType="pubmed">32389704</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheraton M, Deo N, Kashyap R, Surani S. A review of neurological complications of COVID&#x2010;19. Cureus 2020; 12: e8192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243063</ArticleId><ArticleId IdType="pubmed">32455089</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID&#x2010;19 virus targeting the CNS: tissue distribution, host&#x2010;virus interaction, and proposed neurotropic mechanisms. American Chemical Society Chemical Neuroscience 2020; 11: 995&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">32167747</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayi BS, Leibowitz JA, Woods AT, Ammon KA, Liu AE, Raja A. The role of neuropilin&#x2010;1 in COVID&#x2010;19. PLoS Pathogens 2021; 17: e1009153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7781380</ArticleId><ArticleId IdType="pubmed">33395426</ArticleId></ArticleIdList></Reference><Reference><Citation>Moutal A, Martin LF, Boinon L, et&#x2009;al. SARS&#x2010;CoV&#x2010;2 spike protein co&#x2010;opts VEGF&#x2010;A/neuropilin&#x2010;1 receptor signaling to induce analgesia. Pain 2021; 162: 243&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7737878</ArticleId><ArticleId IdType="pubmed">33009246</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand H, Ende V, Singh G, Qureshi I, Duong TQ, Mehler MF. Nervous system&#x2010;systemic crosstalk in SARS&#x2010;CoV&#x2010;2/COVID&#x2010;19: a unique dyshomeostasis syndrome. Frontiers in Neuroscience 2021; 15: 727060.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8430330</ArticleId><ArticleId IdType="pubmed">34512253</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay A. A paradigm for post&#x2010;Covid&#x2010;19 fatigue syndrome analogous to ME/CFS. Frontiers in Neurology 2021; 12: 701419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8365156</ArticleId><ArticleId IdType="pubmed">34408721</ArticleId></ArticleIdList></Reference><Reference><Citation>
Clinicatrials.gov
. Impact of colchicine and low&#x2010;dose naltrexone on COVID&#x2010;19 (COLTREXONE). https://clinicaltrials.gov/ct2/show/NCT04756128 (accessed 14/02/2022).</Citation></Reference><Reference><Citation>
Canadian Institutes of Health Research
. A double blind randomized trial of low&#x2010;dose naltrexone for post&#x2010;covid fatigue syndrome. https://webapps.cihr&#x2010;irsc.gc.ca/decisions/p/project_details.html?applId=448902&amp;lang=en (accessed 14/02/2022).</Citation></Reference><Reference><Citation>Choubey A, Dehury B, Kumar S, Medhi B, Mondal P. Naltrexone a potential therapeutic candidate for COVID&#x2010;19. Journal of Biomolecular Structure and Dynamics 2022; 40: 963&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7544934</ArticleId><ArticleId IdType="pubmed">32930058</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, et&#x2009;al. Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. Clinical Medicine 2021; 21: e63&#x2013;e67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Porzionato A, Emmi A, Barbon S, et&#x2009;al. Sympathetic activation: a potential link between comorbidities and COVID&#x2010;19. Federation of European Biochemical Societies Journal 2020; 287: 3681&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7405290</ArticleId><ArticleId IdType="pubmed">32779891</ArticleId></ArticleIdList></Reference><Reference><Citation>Al&#x2010;Kuraishy HM, Al&#x2010;Gareeb AI, Qusti S, Alshammari EM, Gyebi GA, Batiha GE. Covid&#x2010;19&#x2010;induced dysautonomia: a menace of sympathetic storm. American Society for Neurochemistry Neurology 2021; 13: 17590914211057635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8586167</ArticleId><ArticleId IdType="pubmed">34755562</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer L, Barop H, Ludin SM, Schaible HG. Regulation of acute reflectory hyperinflammation in viral and other diseases by means of stellate ganglion block. A conceptual view with a focus on Covid&#x2010;19. Autonomic Neuroscience: Basic and Clinical 2022; 237: 102903.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9761017</ArticleId><ArticleId IdType="pubmed">34894589</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado FC, Carone Neto G, Carone RSD. Sphenopalatine ganglion block for refractory COVID&#x2010;19 headache: a descriptive case series. Brazilian Journal of Anesthesiology 2021; 71: 667&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8080502</ArticleId><ArticleId IdType="pubmed">33932392</ArticleId></ArticleIdList></Reference><Reference><Citation>Mojica J, Mo B, Ng A. Sphenopalatine ganglion block in the management of chronic headaches. Current Pain and Headache Reports 2017; 21: 27.</Citation><ArticleIdList><ArticleId IdType="pubmed">28432602</ArticleId></ArticleIdList></Reference><Reference><Citation>Siepmann T, Sedghi A, Simon E, et&#x2009;al. Increased risk of acute stroke among patients with severe COVID&#x2010;19: a multicenter study and meta&#x2010;analysis. European Journal of Neurology 2021; 28: 238&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">32920964</ArticleId></ArticleIdList></Reference><Reference><Citation>Carda S, Invernizzi M, Bavikatte G, et&#x2009;al. COVID&#x2010;19 pandemic. What should physical and rehabilitation medicine specialists do? A clinician's perspective. European Journal of Physical and Rehabilitation Medicine 2020; 56: 515&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">32434314</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia&#x2010;Esquinas E, Ortola R, Gine&#x2010;Vazquez I, et&#x2009;al. Changes in health behaviors, mental and physical health among older adults under severe lockdown restrictions during the COVID&#x2010;19 pandemic in Spain. International Journal of Environmental Research and Public Health 2021; 18: 7067.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8297096</ArticleId><ArticleId IdType="pubmed">34281004</ArticleId></ArticleIdList></Reference><Reference><Citation>Miro J, Sanchez&#x2010;Rodriguez E, Ferreira&#x2010;Valente A, Pais&#x2010;Ribeiro J, Ciaramella A. Effects of COVID&#x2010;19 social distancing measures in individuals with chronic pain living in Spain in the late stages of the lockdown. International Journal of Environmental Research and Public Health 2021; 18: 11732.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8624638</ArticleId><ArticleId IdType="pubmed">34831489</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieto R, Pardo R, Sora B, Feliu&#x2010;Soler A, Luciano JV. Impact of COVID&#x2010;19 lockdown measures on Spanish people with chronic pain: an online study survey. Journal of Clinical Medicine 2020; 9: 3558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7694344</ArticleId><ArticleId IdType="pubmed">33167322</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallon N, Brown C, Twiddy H, et&#x2009;al. Adverse effects of COVID&#x2010;19&#x2010;related lockdown on pain, physical activity and psychological well&#x2010;being in people with chronic pain. British Journal of Pain 2021; 15: 357&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8339954</ArticleId><ArticleId IdType="pubmed">34377461</ArticleId></ArticleIdList></Reference><Reference><Citation>Mun CJ, Campbell CM, McGill LS, Aaron RV. The early impact of COVID&#x2010;19 on chronic pain: a cross&#x2010;sectional investigation of a large online sample of individuals with chronic pain in the United States, April to may, 2020. Pain Medicine 2021; 22: 470&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7901854</ArticleId><ArticleId IdType="pubmed">33537764</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MG, Lacasse A, Dassieu L, et&#x2009;al. A cross&#x2010;sectional study of pain status and psychological distress among individuals living with chronic pain: the chronic pain &amp; COVID&#x2010;19 pan&#x2010;Canadian study. Health Promotion and Chronic Disease Prevention in Canada 2021; 41: 141&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">33570487</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimoto T, Fujii T, Oka H, Kasahara S, Kawamata K, Matsudaira K. Pain status and its association with physical activity, psychological stress, and telework among Japanese workers with pain during the Covid&#x2010;19 pandemic. International Journal of Environmental Research and Public Health 2021; 18: 5595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8197253</ArticleId><ArticleId IdType="pubmed">34073863</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang&#x2010;Illievich K, Rumpold&#x2010;Seitlinger G, Szilagyi IS, et&#x2009;al. Biological, psychological, and social factors associated with worsening of chronic pain during the first wave of the COVID&#x2010;19 pandemic: a cross&#x2010;sectional survey. British Journal of Anaesthesia 2021; 127: e37&#x2013;e39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9246506</ArticleId><ArticleId IdType="pubmed">33992397</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilke J, Hollander K, Mohr L, et&#x2009;al. Drastic reductions in mental well&#x2010;being observed globally during the COVID&#x2010;19 pandemic: results from the ASAP survey. Frontiers in Medicine 2021; 8: 578959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8032868</ArticleId><ArticleId IdType="pubmed">33842492</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasturi S, Price LL, Paushkin V, Salmon JE, McAlindon TE, Mandl LA. Impact of the first wave of the COVID&#x2010;19 pandemic on systemic lupus erythematosus patients: results from a multi&#x2010;center prospective cohort. Lupus 2021; 30: 1747&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8560554</ArticleId><ArticleId IdType="pubmed">34284676</ArticleId></ArticleIdList></Reference><Reference><Citation>Macfarlane GJ, Hollick RJ, Morton L, et&#x2009;al. The effect of COVID&#x2010;19 public health restrictions on the health of people with musculoskeletal conditions and symptoms: the CONTAIN study. Rheumatology 2021; 60: SI13&#x2013;SI24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8244573</ArticleId><ArticleId IdType="pubmed">34009314</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadun R, Rogers J, Sun K, et&#x2009;al. The impact of the COVID&#x2010;19 pandemic on the fibromyalgia symptoms of SLE patients. Arthritis and Rheumatology 2020; 72: 2557&#x2013;9.</Citation></Reference><Reference><Citation>Zambelli Z, Fidalgo AR, Halstead EJ, Dimitriou D. Acute impact of a national lockdown during the COVID&#x2010;19 pandemic on wellbeing outcomes among individuals with chronic pain. Journal of Health Psychology 2021; 27: 1359105321995962.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8978477</ArticleId><ArticleId IdType="pubmed">33601977</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwab R, Ani&#x107; K, Stewen K, et&#x2009;al. Pain experience and social support of endometriosis patients during the COVID&#x2010;19 pandemic in Germany &#x2010; results of a web&#x2010;based cross&#x2010;sectional survey. PLoS One 2021; 16: e0256433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8386836</ArticleId><ArticleId IdType="pubmed">34432847</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujiwara A, Watanabe K, Ida M, et&#x2009;al. The short&#x2010;term effect of COVID&#x2010;19 pandemic on disability, pain intensity, psychological status, and exercise habits in patients with chronic pain. Journal of Anesthesia 2021; 35: 862&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8386678</ArticleId><ArticleId IdType="pubmed">34435236</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasseli R, Muller&#x2010;Ladner U, Schmeiser T, et&#x2009;al. Disease activity and pain levels are not influenced by the current COVID19 pandemic in patients with rheumatic diseases in Germany&#x2010;data from the German COVID&#x2010;19 patient survey. Annals of the Rheumatic Diseases 2021; 80: 915.</Citation></Reference><Reference><Citation>Kersebaum D, Fabig SC, Sendel M, et&#x2009;al. The early influence of COVID&#x2010;19 pandemic&#x2010;associated restrictions on pain, mood, and everyday life of patients with painful polyneuropathy. Pain Reports 2020; 5: e858.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7566868</ArticleId><ArticleId IdType="pubmed">33134753</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassen CL, Siam L, Degenhart A, Klier TW, Bundscherer A, Lindenberg N. Short&#x2010;term impact of the COVID&#x2010;19 pandemic on patients with a chronic pain disorder. Medicine 2021; 100: e25153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7969217</ArticleId><ArticleId IdType="pubmed">33725917</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonza A, da Cunha de S&#xe1;&#x2010;Caputo D, Sartorio A, et&#x2009;al. COVID&#x2010;19 lockdown and the behavior change on physical exercise, pain and psychological well&#x2010;being: an international multicentric study. International Journal of Environmental Research and Public Health 2021; 18: 3810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8038730</ArticleId><ArticleId IdType="pubmed">33917363</ArticleId></ArticleIdList></Reference><Reference><Citation>Kieser DC, Bourghli A, Larrieu D, et&#x2009;al. Impact of COVID&#x2010;19 on the pain and disability of patients with adult spinal deformity. Spine Deformity 2021; 9: 1073&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7923403</ArticleId><ArticleId IdType="pubmed">33651340</ArticleId></ArticleIdList></Reference><Reference><Citation>Licciardone JC. Impact of COVID&#x2010;19 on utilization of nonpharmacological and pharmacological treatments for chronic low back pain and clinical outcomes. Journal of Osteopathic Medicine 2021; 121: 625&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">33770828</ArticleId></ArticleIdList></Reference><Reference><Citation>Licciardone JC. Demographic characteristics associated with utilization of noninvasive treatments for chronic low back pain and related clinical outcomes during the COVID&#x2010;19 pandemic in the United States. Journal of the American Board of Family Medicine 2021; 34: S77&#x2013;S84.</Citation><ArticleIdList><ArticleId IdType="pubmed">33622822</ArticleId></ArticleIdList></Reference><Reference><Citation>Dassieu L, Page MG, Lacasse A, et&#x2009;al. Chronic pain experience and health inequities during the COVID&#x2010;19 pandemic in Canada: qualitative findings from the chronic pain &amp; COVID&#x2010;19 pan&#x2010;Canadian study. International Journal for Equity in Health 2021; 20: 147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8220113</ArticleId><ArticleId IdType="pubmed">34162393</ArticleId></ArticleIdList></Reference><Reference><Citation>Hruschak V, Flowers KM, Azizoddin DR, Jamison RN, Edwards RR, Schreiber KL. Cross&#x2010;sectional study of psychosocial and pain&#x2010;related variables among patients with chronic pain during a time of social distancing imposed by the coronavirus disease 2019 pandemic. Pain 2021; 162: 619&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808279</ArticleId><ArticleId IdType="pubmed">33230007</ArticleId></ArticleIdList></Reference><Reference><Citation>Koppert TY, Jacobs JWG, Lumley MA, Geenen R. The impact of COVID&#x2010;19 stress on pain and fatigue in people with and without a central sensitivity syndrome. Journal of Psychosomatic Research 2021; 151: 110655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8553422</ArticleId><ArticleId IdType="pubmed">34739944</ArticleId></ArticleIdList></Reference><Reference><Citation>Law EF, Zhou C, Seung F, Perry F, Palermo TM. Longitudinal study of early adaptation to the coronavirus disease pandemic among youth with chronic pain and their parents: effects of direct exposures and economic stress. Pain 2021; 162: 2132&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8205975</ArticleId><ArticleId IdType="pubmed">34050112</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Zhao N, Yan X, et&#x2009;al. The prevalence of depressive and anxiety symptoms and their associations with quality of life among clinically stable older patients with psychiatric disorders during the COVID&#x2010;19 pandemic. Translational Psychiatry 2021; 11: 75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7835649</ArticleId><ArticleId IdType="pubmed">33500389</ArticleId></ArticleIdList></Reference><Reference><Citation>Harnik MA, Blattler L, Limacher A, et&#x2009;al. Telemedicine for chronic pain treatment during the COVID&#x2010;19 pandemic: do pain intensity and anxiousness correlate with patient acceptance? Pain Practice 2021; 21: 934&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8646884</ArticleId><ArticleId IdType="pubmed">34463025</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleinmann B, Abberger B, Kieselbach K, Wolter T. Patients with chronic pain prefer maintenance of pain treatment despite COVID&#x2010;19 pandemic restrictions. Pain Physician 2021; 24: 165&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">33740352</ArticleId></ArticleIdList></Reference><Reference><Citation>Teuschl Y, Bancher C, Brainin M, Dachenhausen A, Matz K, Pinter MM. COVID&#x2010;19&#x2010;related delays of botulinum toxin injections have a negative impact on the quality of life of patients with dystonia and spasticity: a single&#x2010;center ambulatory care study. Journal of Neural Transmission 2022; 129: 49&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8541799</ArticleId><ArticleId IdType="pubmed">34689260</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention
. Provisional drug overdose death counts. 2022. https://www.cdc.gov/nchs/nvss/vsrr/drug&#x2010;overdose&#x2010;data.htm (accessed 21/02/2022).</Citation></Reference><Reference><Citation>American Medical Association . Nation's drug&#x2010;related overdose and death epidemic continues to worsen. 2021.</Citation></Reference><Reference><Citation>Pierce M, van Amsterdam J, Kalkman GA, Schellekens A, van den Brink W. Is Europe facing an opioid crisis like the United States? An analysis of opioid use and related adverse effects in 19 European countries between 2010 and 2018. European Psychiatry 2021; 64: e47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8316471</ArticleId><ArticleId IdType="pubmed">34165059</ArticleId></ArticleIdList></Reference><Reference><Citation>
Choudhury L. The impact of COVID&#x2010;19 on harm reduction in seven Asian countries. 2020. https://www.hri.global/files/2020/12/07/HRI&#x2010;COVID&#x2010;Report.pdf (accessed 15/05/2022).</Citation></Reference><Reference><Citation>
European Monitoring Centre for Drugs and Drug Addiction
. EMCDDA Trendspotter briefing: impact of COVID&#x2010;19 on patterns of drug use and drug&#x2010;related harms in Europe. 2020. https://www.emcdda.europa.eu/publications/ad&#x2010;hoc&#x2010;publication/impact&#x2010;covid&#x2010;19&#x2010;patterns&#x2010;drug&#x2010;use&#x2010;and&#x2010;harms_en (accessed 15/05/2022).</Citation></Reference><Reference><Citation>Martin L, Dowling A, Mishra S. The detrimental impact of COVID&#x2010;19 on chronic pain patients. Anaesthesia 2021; 76: 61.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Neville A, Lund T, Soltani S, et&#x2009;al. Pediatric chronic pain in the midst of the COVID&#x2010;19 pandemic: lived experiences of youth and parents. Journal of Pain 2021; 13: 13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8710941</ArticleId><ArticleId IdType="pubmed">34915200</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano&#x2010;Ibanez ER, Esteve R, Ramirez&#x2010;Maestre C, Ruiz&#x2010;Parraga GT, Lopez&#x2010;Martinez AE. Chronic pain in the time of COVID&#x2010;19: stress aftermath and central sensitization. British Journal of Health Psychology 2021; 26: 544&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">33099793</ArticleId></ArticleIdList></Reference><Reference><Citation>Rassu FS, McFadden M, Aaron RV, et&#x2009;al. The relationship between neighborhood deprivation and perceived changes for pain&#x2010;related experiences among US patients with chronic low back pain during the COVID&#x2010;19 pandemic. Pain Medicine 2021; 22: 2550&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8633737</ArticleId><ArticleId IdType="pubmed">34181008</ArticleId></ArticleIdList></Reference><Reference><Citation>Smyrnioti ME, Lyrakos G, Meindani M, Matsota P, Kostopanagiotou G, Batistaki C. The impact of the first wave of the COVID&#x2010;19 pandemic on patients' perceptions of chronic pain. Journal of Pain Research 2021; 14: 2571&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8387638</ArticleId><ArticleId IdType="pubmed">34456587</ArticleId></ArticleIdList></Reference><Reference><Citation>Steptoe A, Di Gessa G. Mental health and social interactions of older people with physical disabilities in England during the COVID&#x2010;19 pandemic: a longitudinal cohort study. Lancet Public Health 2021; 6: e365&#x2013;e73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8517412</ArticleId><ArticleId IdType="pubmed">33894138</ArticleId></ArticleIdList></Reference><Reference><Citation>Flowers KM, Colebaugh CA, Hruschak V, et&#x2009;al. Introversion buffers pandemic&#x2010;related increases in chronic pain impact. Journal of Pain 2021; 22: 611&#x2013;2.</Citation></Reference><Reference><Citation>Geneen LJ, Moore RA, Clarke C, Martin D, Colvin LA, Smith BH. Physical activity and exercise for chronic pain in adults: an overview of Cochrane reviews. Cochrane Database of Systematic Reviews 2017; 4: CD011279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5461882</ArticleId><ArticleId IdType="pubmed">28436583</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy H, Potts HWW, Fisher A. Physical activity behavior before, during, and after COVID&#x2010;19 restrictions: longitudinal smartphone&#x2010;tracking study of adults in the United Kingdom. Journal of Medical Internet Research 2021; 23: e23701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7861037</ArticleId><ArticleId IdType="pubmed">33347421</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Koenigstorfer J. Determinants of physical activity maintenance during the Covid&#x2010;19 pandemic: a focus on fitness apps. Translational Behavioral Medicine 2020; 10: 835&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7797716</ArticleId><ArticleId IdType="pubmed">32926160</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L, Kioskli K, McCracken LM. The psychological functioning in the COVID&#x2010;19 pandemic and its association with psychological flexibility and broader functioning in people with chronic pain. Journal of Pain 2021; 22: 926&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7930808</ArticleId><ArticleId IdType="pubmed">33677112</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H, Punt JA, Patel J, Stojanovic MP, Duszynski B, McCormick ZL. Do corticosteroid injections for the treatment of pain influence the efficacy of adenovirus vector&#x2010;based COVID&#x2010;19 vaccines? Pain Medicine 2021; 22: 1441&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083288</ArticleId><ArticleId IdType="pubmed">33839780</ArticleId></ArticleIdList></Reference><Reference><Citation>Deepak P, Kim W, Paley MA, et&#x2009;al. Effect of immunosuppression on the immunogenicity of mRNA vaccines to SARS&#x2010;CoV&#x2010;2: a prospective cohort study. Annals of Internal Medicine 2021; 174: 1572&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8407518</ArticleId><ArticleId IdType="pubmed">34461029</ArticleId></ArticleIdList></Reference><Reference><Citation>Furer V, Eviatar T, Zisman D, et&#x2009;al. Immunogenicity and safety of the BNT162b2 mRNA COVID&#x2010;19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Annals of the Rheumatic Diseases 2021; 80: 1330&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">34127481</ArticleId></ArticleIdList></Reference><Reference><Citation>Y&#x131;ld&#x131;z N, Sever L, Kasap&#xe7;opur &#xd6;, &#xc7;ullu F, Ar&#x131;soy N, &#xc7;al&#x131;&#x15f;kan S. Hepatitis B virus vaccination in children with steroid sensitive nephrotic syndrome: immunogenicity and safety? Vaccine 2013; 31: 3309&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">23684838</ArticleId></ArticleIdList></Reference><Reference><Citation>Aikawa NE, Campos LM, Silva CA, et&#x2009;al. Glucocorticoid: major factor for reduced immunogenicity of 2009 influenza a (H1N1) vaccine in patients with juvenile autoimmune rheumatic disease. Journal of Rheumatology 2012; 39: 167&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">22089462</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer L, Gerstel PF, Poncet A, et&#x2009;al. Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases&#x2010;&#x2010;a longitudinal study. Arthritis Research and Therapy 2015; 17: 151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4481118</ArticleId><ArticleId IdType="pubmed">26048579</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JR, Denis R, Lucas CE, et&#x2009;al. The effect of steroids for shock on the immune response to tetanus toxoid. American Surgeon 1987; 53: 389&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">3605856</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairchok MP, Trementozzi DP, Carter PS, Regnery HL, Carter ER. Effect of prednisone on response to influenza virus vaccine in asthmatic children. Archives of Pediatrics and Adolescent Medicine 1998; 152: 1191&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">9856428</ArticleId></ArticleIdList></Reference><Reference><Citation>Park CL, Frank AL, Sullivan M, Jindal P, Baxter BD. Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy. Pediatrics 1996; 98: 196&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">8692617</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadoff J, Gray G, Vandebosch A, et&#x2009;al. Safety and efficacy of single&#x2010;dose Ad26.COV2.S vaccine against Covid&#x2010;19. New England Journal of Medicine 2021; 384: 2187&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8220996</ArticleId><ArticleId IdType="pubmed">33882225</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbaeyi S, Oliver SE, Collins JP, et&#x2009;al. The advisory committee on immunization Practices' interim recommendations for additional primary and booster doses of COVID&#x2010;19 vaccines &#x2010; United States, 2021. Morbidity and Mortality Weekly Report 2021; 70: 1545&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8568093</ArticleId><ArticleId IdType="pubmed">34735422</ArticleId></ArticleIdList></Reference><Reference><Citation>Naranbhai V, Pernat CA, Gavralidis A, et&#x2009;al. Immunogenicity and reactogenicity of SARS&#x2010;CoV&#x2010;2 vaccines in patients with cancer: the CANVAX cohort study. Journal of Clinical Oncology 2022; 40: 12&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8683230</ArticleId><ArticleId IdType="pubmed">34752147</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan N, Mahmud N. Effectiveness of SARS&#x2010;CoV&#x2010;2 vaccination in a veterans affairs cohort of patients with inflammatory bowel disease with diverse exposure to immunosuppressive medications. Gastroenterology 2021; 161: 827&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146263</ArticleId><ArticleId IdType="pubmed">34048782</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuck AE, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticosteroids. Reviews of Infectious Diseases 1989; 11: 954&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">2690289</ArticleId></ArticleIdList></Reference><Reference><Citation>Galimberti F, McBride J, Cronin M, et&#x2009;al. Evidence&#x2010;based best practice advice for patients treated with systemic immunosuppressants in relation to COVID&#x2010;19. Clinics in Dermatology 2020; 38: 775&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7224642</ArticleId><ArticleId IdType="pubmed">32419721</ArticleId></ArticleIdList></Reference><Reference><Citation>McKean D, Chung SL, Fairhead R, et&#x2009;al. Corticosteroid injections during the COVID&#x2010;19 pandemic: experience from a UK centre. Bone and Joint Open 2020; 1: 605&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7659632</ArticleId><ArticleId IdType="pubmed">33215158</ArticleId></ArticleIdList></Reference><Reference><Citation>Papp KA, Haraoui B, Kumar D, et&#x2009;al. Vaccination guidelines for&#x2009;patients with immune&#x2010;mediated disorders on immunosuppressive therapies. Journal of Cutaneous Medicine and Surgery 2019; 23: 50&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6330697</ArticleId><ArticleId IdType="pubmed">30463418</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiore AE, Uyeki TM, Broder K, et&#x2009;al. Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices (ACIP), 2010. Morbidity and Mortality Weekly Report 2010; 59: 1&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">20689501</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention
. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer&#x2010;BioNTech COVID&#x2010;19 Vaccine &#x2014; United States, December 2020. https://www.cdc.gov/mmwr/volumes/69/wr/mm6950e2.htm (accessed 15/02/2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7745957</ArticleId><ArticleId IdType="pubmed">33332292</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch ME, Williamson OD, Banfield JC. COVID&#x2010;19 impact and response by Canadian pain clinics: a national survey of adult pain clinics. Canadian Journal of Pain 2020; 4: 204&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7951169</ArticleId><ArticleId IdType="pubmed">33987499</ArticleId></ArticleIdList></Reference><Reference><Citation>Whaley CM, Pera MF, Cantor J, et&#x2009;al. Changes in health services use among commercially insured US populations during the COVID&#x2010;19 pandemic. Journal of the American Medical Association Network Open 2020; 3: e2024984.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7645698</ArticleId><ArticleId IdType="pubmed">33151319</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow RM, Rajput K, Howie BA, Varhabhatla N. The COVID&#x2010;19 vaccine and interventional procedures: exploring the relationship between steroid administration and subsequent vaccine efficacy. Pain Practice 2021; 21: 966&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8420220</ArticleId><ArticleId IdType="pubmed">34314563</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>